Clinical Study

Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy Subjects

Table 1

Clinical and laboratory characteristics of the study population before and after T3 administration.

ParameterBefore T3After T3P value

Heart rate, beats/min 7 2 ± 7 7 5 ± 6 .061
Mean blood pressure, mmHg 1 1 7 ± 1 3 1 1 7 ± 1 0 .966
T3, nmol/L 1 . 8 0 ± 0 . 6 4 . 3 ± 1 . 0 < .001
T4, nmol/L 1 0 7 ± 1 8 9 7 ± 2 0 .018
TSH, μU/mL 1 . 0 4 ± 0 . 7 0 0 . 0 9 ± 0 . 0 4 < .001
ANP, pmol/L 1 0 . 4 ± 2 . 9 1 1 . 8 ± 4 . 9 .256
PRA, nmol/L/h 1 . 8 ± 1 . 2 3 2 . 2 ± 0 . 9 .099
ALDO, pmol/L 6 3 3 ± 4 7 2 6 6 5 ± 3 2 5 .836

ALDO: plasma aldosterone; ANP: plasma atrial natriuretic peptide; PRA, plasma renin activity.